 |
 |
|
        |
|
Our People
Cathy Ferrone, senior associate David Golub, vice president Heather Hollowell, senior director Mark Krueger, president Jean Mossman, managing director, Europe Anne Olshan, senior consultant Amber Spierer, senior associate Mark Krueger, MPH President Mark Krueger, president, founded Mark Krueger & Associates, Inc., in 1996 to help pharmaceutical, biotech, device, and diagnostic companies partner with patient, consumer, and professional groups to speed drug, device, and diagnostic development and approval; promote appropriate use; and ensure equitable access and reimbursement. He brings 25 years of public health and advocacy experience to the firm and has earned respect for his strategic approach to building equitable and responsible partnerships with patients, families, advocates, physicians and other health care professionals, and policy makers. Under Mark’s direction, MK&A has created a unique niche in global health care through its singular focus on advocacy. The firm has demonstrated repeatedly that integration of patient, consumer and professional groups’ viewpoints can create better health care for all. Notable among MK&A’s achievements are the return of thalidomide to legitimate use; registration and approval of more than 10 orphan drugs; planning and implementation of the world’s largest pre-approval drug access program; development of post-approval humanitarian drug distribution programs; resolution of conflicts with industry critics; building of internal ally relations capacity where none previously existed in three global research and development-based pharmaceutical companies; and creation of guidelines and systems that promote equitable and compliant partnerships between industry and allies in North America, Europe, and other countries. Prior to launching the firm, Mark was vice president and director of coalition building for GTFH, then the largest public relations, marketing, and government relations firm solely dedicated to health and medicine. Previously, Mark spent six years in a variety of senior management positions at the American Foundation for AIDS Research (amfAR), including special assistant to founding co-chair Mathilde Krim, Ph.D. Mark is recognized for his comprehensive knowledge of HIV/AIDS, other infectious diseases, oncology, orphan disorders and women's health. He is well known for his mediation and facilitation skills as well as his understanding of the changing external environment for ally relations and appropriate responses to legislative, regulatory, ally group, and public expectations. In addition to his leadership role at MK&A, Mark is a member of the national advisory board of the National Organization for Rare Disorders (NORD) and an honorary member of EURORDIS. He is also a member of the board of directors of the National Ovarian Cancer Coalition and the public relations committee of Cancer Care. Mark holds a B.A. from the College of Columbia University and an M.P.H. from Columbia’s Joseph A. Mailman Graduate School of Public Health.
You may contact Mark at mkrueger@kruegerandassociates.com
|
|